EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis

Joe E Mouawad iD, Carol Feghali-Bostwick iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24032963 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Joe E Mouawad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology & Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. Hauptthemen laut MEDLINE: Pulmonary Fibrosis, Scleroderma, Systemic, Lung Diseases, Interstitial. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Scleroderma Foundation, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis (SSc), also known as scleroderma, is an autoimmune disorder that affects the connective tissues and has the highest mortality rate among the rheumatic diseases. One of the hallmarks of SSc is fibrosis, which may develop systemically, affecting the skin and virtually any visceral organ in the body. Fibrosis of the lungs leads to interstitial lung disease (ILD), which is currently the leading cause of death in SSc. The identification of effective treatments to stop or reverse lung fibrosis has been the main challenge in reducing SSc mortality and improving patient outcomes and quality of life. Thus, understanding the molecular mechanisms, altered pathways, and their potential interactions in SSc lung fibrosis is key to developing potential therapies. In this review, we discuss the diverse molecular mechanisms involved in SSc-related lung fibrosis to provide insights into the altered homeostasis state inherent to this fatal disease complication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary FibrosisScleroderma, SystemicLung Diseases, InterstitialHumansQuality of LifeLungFibrosis

Stichwörter der Autor:innen

fibroblastfibrosisinterstitial lung diseaselungmolecular mechanismspulmonarysclerodermasystemic sclerosis

Autor:innen und Institutionen

  • Division of Rheumatology & Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
  • Medical Scientist Training Program, Medical University of South Carolina, Charleston, SC 29425, USA.

ORCID-Profile: Joe E Mouawad, Carol Feghali-Bostwick

Förderung

  • NIH HHS
  • National Scleroderma Foundation
  • NIH

Zitieren

APA

Mouawad, J. E., & Feghali-Bostwick, C. (2023). The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032963

Vancouver

Mouawad JE, Feghali-Bostwick C. The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032963

BibTeX
@article{Mouawad2023,
  author = {Mouawad, Joe E and Feghali-Bostwick, Carol},
  title = {The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24032963}
}
Kostenlos starten →